These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 17041243)

  • 1. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health risks of engineered nanomaterials and nanotechnologies].
    Savolainen K; Vainio H
    Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational safety and health's role in sustainable, responsible nanotechnology: gaps and needs.
    Iavicoli S; Rondinone BM; Boccuni F
    Hum Exp Toxicol; 2009 Jun; 28(6-7):433-43. PubMed ID: 19755456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano risk analysis: advancing the science for nanomaterials risk management.
    Shatkin JA; Abbott LC; Bradley AE; Canady RA; Guidotti T; Kulinowski KM; Löfstedt RE; Louis G; MacDonell M; Maynard AD; Paoli G; Sheremeta L; Walker N; White R; Williams R
    Risk Anal; 2010 Nov; 30(11):1680-7. PubMed ID: 20846172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of research to the responsible and sustainable development of nanotechnologies].
    Iavicoli S; Boccuni F
    G Ital Med Lav Ergon; 2008; 30(3 Suppl):110-4. PubMed ID: 19288800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nanotubes and fullerenes: an overview of the possible environmental and biological impact of bio-nanotechnologies].
    Bottini M; Magrini A; Bottini N; Bergamaschi A
    Med Lav; 2003; 94(6):497-505. PubMed ID: 14768242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance for handling and use of nanomaterials at the workplace.
    Heinemann M; Schäfer HG
    Hum Exp Toxicol; 2009 Jun; 28(6-7):407-11. PubMed ID: 19755453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management of nanomaterials.
    Gwinn MR; Tran L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):130-7. PubMed ID: 20077523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health effects of engineered nanomaterials].
    Pietroiusti A; Magrini A; Bergamaschi A; Iavicoli I
    G Ital Med Lav Ergon; 2010; 32(4 Suppl):287-9. PubMed ID: 21438282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology: are occupational health nurses ready?
    McCauley LA; McCauley RD
    AAOHN J; 2005 Dec; 53(12):517-21. PubMed ID: 16401058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC; Maynard AD
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
    Thomas T; Bahadori T; Savage N; Thomas K
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
    Thomas K; Sayre P
    Toxicol Sci; 2005 Oct; 87(2):316-21. PubMed ID: 16049265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterials and lung toxicity: interactions with airways cells and relevance for occupational health risk assessment.
    Bergamaschi E; Bussolati O; Magrini A; Bottini M; Migliore L; Bellucci S; Iavicoli I; Bergamaschi A
    Int J Immunopathol Pharmacol; 2006; 19(4 Suppl):3-10. PubMed ID: 17291399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.
    Tinkle SS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):88-98. PubMed ID: 20049833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.